Zymergen Gets Conditional OK For Ch. 11 Asset Sales

By Alex Wittenberg · December 19, 2023, 1:53 PM EST

A Delaware bankruptcy judge on Tuesday signaled she would approve biotechnology company Zymergen's asset sales to two bidders as part of its Chapter 11 liquidation plan, under an agreement whereby the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Case Number

Court

Delaware

Nature of Suit

Date Filed

October 03, 2023

Recent Articles By Alex

October 29, 2024
PE-Owned Implant Maker Plagued By Lawsuits Hits Ch. 11
October 15, 2024
Sacklers Say Opioid Claims Can't Undo Purdue Transfers
June 07, 2024
Acorda Therapeutics Gets OK On $185M Ch. 11 Sale To Merz
March 01, 2024
Plaintiffs Blast Prison Health Co.'s 'Potemkin Village' Case
December 20, 2023
Stimwave Buyer Can Enforce Sale In 'Disturbing' Domain Row
December 01, 2023
Leases Don't Disqualify Small Biz Bankruptcies, Court Rules
November 29, 2023
Oncology Co. Akumin Gets OK For Take-Private Ch. 11 Plan
November 06, 2023
Justices Grant Purdue Creditors Separate Argument Time
October 24, 2023
Med-Tech Co. UpHealth And 6 Units Get OK For Joint Ch. 11
October 23, 2023
High Court Told Purdue's Ch. 11 Liability Waiver Is Legal